Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Julie H Ishida"'
Autor:
Julie H Ishida, Peggy O Wong, Beth E Cohen, Marzieh Vali, Stacey Steigerwald, Salomeh Keyhani
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222577 (2019)
Opioid prescriptions for chronic pain and subsequent opioid-related complications have risen dramatically in the US. Recent data suggest that medical marijuana laws have been associated with lower state-level opioid overdose mortality. In a national
Externí odkaz:
https://doaj.org/article/73edb768875443d4828f2ccfa8d6a7f9
Autor:
Jinnie J. Rhee, Yuanchao Zheng, Sai Liu, Maria E. Montez-Rath, Richard J. Hamill, Julie H. Ishida, Wolfgang C. Winkelmayer
Publikováno v:
Kidney International Reports, Vol 5, Iss 7, Pp 1014-1025 (2020)
Introduction: Patients with diabetes mellitus (DM) on hemodialysis (HD) may be particularly vulnerable to infections. Methods: We used merged data from the United States Renal Data System and electronic health records data from a large US dialysis pr
Externí odkaz:
https://doaj.org/article/4ddedd299bf84112a550af08a416ee8c
Autor:
Cynthia Chauhan, Julie H. Ishida, David C. Wheeler, Meaghan A. Malley, Ken Gruchalla, Barbara S. Gillespie, Melissa West, Peter A. McCullough, Susan Quella, Patrick Rossignol, Charles A. Herzog, Alain Romero
Publikováno v:
Clin J Am Soc Nephrol
Cardiovascular disease is a prevalent and prognostically important comorbidity among patients with kidney disease, and individuals with kidney disease make up a sizeable proportion (30%-60%) of patients with cardiovascular disease. However, several s
Autor:
Barbara Grimes, Kirsten L. Johansen, Charles E. McCulloch, Michael A. Steinman, Julie H. Ishida
Publikováno v:
Journal of the American Geriatrics Society. 67:449-454
Background Guidelines recommend avoidance of several psychoactive medications such as hypnotics in older adults due to their adverse effects. Older patients on hemodialysis may be particularly vulnerable to complications related to use of these agent
Autor:
Adrian Liew, David C. Wheeler, Kate Chong, Marvin Sinsakul, Mary Beaucage, Mototsugu Tanaka, Jonathan Barratt, Maarten W. Taal, Aminu K. Bello, Charu Malik, Glenda V. Roberts, Hiddo J.L. Heerspink, Yoshihisa Yamada, Laura Sola, Charlotte Jones-Burton, Thomas F. Hiemstra, Reiko Nakashima, Katherine R. Tuttle, Shuchi Anand, Benjamin O. Wolthers, Jo Ann Donner, Takayuki Hamano, Debasish Banerjee, Rajiv Agarwal, Jennifer B. Rose, Ifeoma Ulasi, Masaomi Nangaku, Duane Sunwold, Vlado Perkovic, NB Argent, Robert Lawatscheck, Vivekanand Jha, Richard Haynes, Dick de Zeeuw, Fergus Caskey, Amer Joseph, Madeleine Warren, Michele Trask, Christoph Wanner, Robert D. Toto, Ian H. de Boer, Kenneth W. Mahaffey, Harold M. Wright, Meg Jardine, Hans Vorster, William Canovatchel, Adeera Levin, Kai-Uwe Eckardt, Marcello Tonelli, Noah L. Rosenberg, Hrefna Gudmundsdottir, Rhys Evans, Agnes B. Fogo, David Harris, Thomas Idorn, Amy R. Sood, Sandrine Damster, A. A. Bernardo, David W. Johnson, Saraladevi Naicker, Julie H. Ishida, William E. Smoyer, Roberto Pecoits Filho, Elena Zakharova, William G. Herrington, Shahnaz Shahinfar, Aliza Thompson, Lesley A. Inker, Matthias Kretzler, Allison Tong, Harold I. Feldman, Louise Moist, Josef Coresh, Elena Babak, Sibylle J. Hauske, Jaime D. Blais, Charles A. Herzog, Uptal D. Patel, Johannes F.E. Mann, Audrey Koitka-Weber, Bénédicte Stengel
Publikováno v:
Kidney International, 98(4), 849-859. ELSEVIER SCIENCE INC
Kidney failure is an important outcome for patients, clinicians, researchers, healthcare systems, payers, and regulators. However, no harmonized international consensus definitions of kidney failure and key surrogates of progression to kidney failure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ecbac2a0f27c539402b549d8f4ac63
https://research.rug.nl/en/publications/5984117f-7546-4144-a885-57da66d2520c
https://research.rug.nl/en/publications/5984117f-7546-4144-a885-57da66d2520c
Autor:
Beth E. Cohen, Salomeh Keyhani, Patrick Azcarate, Julie H. Ishida, Alysandra J. Zhang, Stacey Steigerwald
Publikováno v:
J Gen Intern Med
Journal of general internal medicine, vol 35, iss 7
Journal of general internal medicine, vol 35, iss 7
BACKGROUND: The use of marijuana for medical purposes is increasing in parallel with expanding legalization and decreased public perception of harm. Despite this increase in use, it is unclear which medical conditions patients are attempting to treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6241556c4a540e3239c9dbdaf25a4e
https://europepmc.org/articles/PMC7352011/
https://europepmc.org/articles/PMC7352011/
Autor:
Yuanchao Zheng, Jinnie J. Rhee, Sai Liu, Julie H. Ishida, Wolfgang C. Winkelmayer, Maria E. Montez-Rath, Richard J. Hamill
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 5, Iss 7, Pp 1014-1025 (2020)
Kidney International Reports, Vol 5, Iss 7, Pp 1014-1025 (2020)
Introduction Patients with diabetes mellitus (DM) on hemodialysis (HD) may be particularly vulnerable to infections. Methods We used merged data from the United States Renal Data System and electronic health records data from a large US dialysis prov
Autor:
Michael A. Steinman, Charles E. McCulloch, Barbara Grimes, Julie H. Ishida, Kirsten L. Johansen
Publikováno v:
Journal of the American Society of Nephrology. 29:1970-1978
Background Gabapentin and pregabalin are used to manage neuropathic pain, pruritus, and restless legs syndrome in patients on hemodialysis. These patients may be especially predisposed to complications related to these agents, which are renally clear
Autor:
Barbara Grimes, Kirsten L. Johansen, Michael A. Steinman, Julie H. Ishida, Charles E. McCulloch
Publikováno v:
Clinical Journal of the American Society of Nephrology. 13:746-753
Background and objectives Patients on hemodialysis frequently experience pain and may be particularly vulnerable to opioid-related complications. However, data evaluating the risks of opioid use in patients on hemodialysis are limited. Design, settin
Autor:
Kirsten L. Johansen, Eric Vittinghoff, Julie H. Ishida, Reto Auer, Jared P. Reis, Mark J. Pletcher, Carmen A. Peralta, Michael G. Shlipak, Kirsten Bibbins-Domingo, Stephen Sidney
Publikováno v:
Clinical Journal of the American Society of Nephrology. 12:1578-1587
Background and objectives Marijuana use has become more widely accepted in the United States and has been legalized in many areas. Although it is biologically plausible that marijuana could affect kidney function, epidemiologic data are lacking. Desi